Study of ACTR T Cell Product in Combination With Trastuzumab in Subjects With HER2-Positive Advanced Solid Tumor Cancers

Name: Study of ACTR T Cell Product in Combination With Trastuzumab in Subjects With HER2-Positive Advanced Solid Tumor Cancers
License: Public Domain

Cogent Biosciences, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

solid tumor, her-2 protein overexpression

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 143565
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.